Brokerages Expect VERONA PHARMA P/S (VRNA) Will Post Earnings of -$0.61 Per Share

Share on StockTwits

Brokerages expect that VERONA PHARMA P/S (NASDAQ:VRNA) will report earnings of ($0.61) per share for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for VERONA PHARMA P/S’s earnings, with the highest EPS estimate coming in at ($0.50) and the lowest estimate coming in at ($0.73). VERONA PHARMA P/S posted earnings per share of $0.06 in the same quarter last year, which suggests a negative year-over-year growth rate of 1,116.7%. The company is scheduled to report its next earnings results on Tuesday, August 6th.

Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for VERONA PHARMA P/S.

VERONA PHARMA P/S (NASDAQ:VRNA) last released its quarterly earnings results on Tuesday, May 7th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.57) by $0.04.

A number of equities analysts have recently issued reports on VRNA shares. Zacks Investment Research downgraded VERONA PHARMA P/S from a “buy” rating to a “hold” rating and set a $7.25 price target on the stock. in a research note on Saturday, April 27th. BTIG Research started coverage on VERONA PHARMA P/S in a research note on Wednesday, April 17th. They issued a “buy” rating and a $17.00 price target on the stock. Finally, Wedbush restated an “outperform” rating and issued a $58.00 price target (up from $56.00) on shares of VERONA PHARMA P/S in a research note on Monday. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $27.00.

VRNA stock opened at $6.14 on Tuesday. VERONA PHARMA P/S has a 1 year low of $5.52 and a 1 year high of $17.16.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Renaissance Technologies LLC purchased a new position in VERONA PHARMA P/S during the first quarter valued at $76,000. IHT Wealth Management LLC purchased a new position in VERONA PHARMA P/S during the first quarter valued at $113,000. Wedbush Securities Inc. purchased a new position in VERONA PHARMA P/S during the fourth quarter valued at $127,000. Aisling Capital Management LP purchased a new position in VERONA PHARMA P/S during the fourth quarter valued at $4,281,000. Finally, venBio Partners LLC purchased a new position in VERONA PHARMA P/S during the first quarter valued at $5,688,000. Institutional investors own 57.49% of the company’s stock.

VERONA PHARMA P/S Company Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.

Recommended Story: Why is Cost of Capital Important?

Get a free copy of the Zacks research report on VERONA PHARMA P/S (VRNA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for VERONA PHARMA P/S (NASDAQ:VRNA)

Receive News & Ratings for VERONA PHARMA P/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VERONA PHARMA P/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Vail Resorts, Inc.  Announces $1.76 Quarterly Dividend
Vail Resorts, Inc. Announces $1.76 Quarterly Dividend
Dynex Capital Inc Announces Monthly Dividend of $0.18
Dynex Capital Inc Announces Monthly Dividend of $0.18
New Look Vision Group Inc  Declares $0.15 Quarterly Dividend
New Look Vision Group Inc Declares $0.15 Quarterly Dividend
Fidelity Southern Co.  Plans Quarterly Dividend of $0.12
Fidelity Southern Co. Plans Quarterly Dividend of $0.12
Armada Hoffler Properties Inc  Announces Quarterly Dividend of $0.21
Armada Hoffler Properties Inc Announces Quarterly Dividend of $0.21
BK COMMUNICATIO/ADR Announces Annual Dividend of $0.93
BK COMMUNICATIO/ADR Announces Annual Dividend of $0.93


© 2006-2019 Ticker Report